John F Cipollo

Nov 15, 2023 | bioprocessonline.com | John F Cipollo |Nick Hutchinson |FUJIFILM Diosynth Biotechnologies |Alice Levis

Interested in bringing your monoclonal antibody from transfection to GMP drug substance in nine months? Join us for a panel discussion to explore our Accelerated mAb Development Program. Meet our experts who have developed our phase-appropriate and cost-effective program, which is scalable and integrates strategies for risk mitigation. Watch now. The lightning-fast rise of mRNA raised the need for manufacturing standards and consensus on product quality attributes and test methods.

Sep 15, 2023 | bioprocessonline.com | John F Cipollo

By John F. Cipollo, United States Pharmacopeia Messenger RNA (mRNA) is the template for protein synthesis. It serves as an intermediate to transfer the genetic information from DNA in the nucleus to the ribosome sites for translation to protein. It can encode virtually any protein, making it extremely attractive as a new modality for the development of vaccines, cell and gene therapies, oncology treatments, and other applications.